MADRIGAL PHARMACEUTICALS, INC. Retained Earnings
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Retained Earnings of -$2.24 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-30
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$2.24B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$2.18B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$2.09B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$2.03B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$2.24B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$2.18B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | -$2.09B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | -$2.03B 10-Q · filed 2025-11-04 | |
| 2025-06-30 | -$1.92B 10-Q · filed 2025-08-05 | |
| 2025-03-31 | -$1.88B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | -$1.80B 10-K · filed 2026-02-19 | |
| 2024-09-30 | -$1.74B 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$1.64B 10-Q · filed 2024-08-07 | |
| 2024-03-31 | -$1.48B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$1.34B 10-K · filed 2025-02-26 | |
| 2023-09-30 | -$1.22B 10-Q · filed 2023-11-06 | |
| 2023-06-30 | -$1.13B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$1.04B 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$962.66M 10-K · filed 2024-02-28 | |
| 2022-09-30 | -$876.75M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | -$795.56M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | -$724.83M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | -$667.31M 10-K/A · filed 2023-03-03 | |
| 2021-09-30 | -$602.76M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$539.66M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$478.01M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | -$425.46M 10-K · filed 2022-02-24 | |
| 2020-09-30 | -$366.34M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | -$308.38M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | -$259.36M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | -$223.22M 10-K · filed 2021-02-25 | |
| 2019-09-30 | -$195.48M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | -$174.05M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | -$154.35M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | -$139.27M 10-K · filed 2020-02-26 | |
| 2018-09-30 | -$127.80M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$119.28M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | -$112.83M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$106.46M 10-K · filed 2019-02-27 | |
| 2017-09-30 | -$98.02M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$89.65M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | -$81.31M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$75.31M 10-K · filed 2018-03-13 | -$75.31M 10-K · filed 2017-03-31 |
| 2016-09-30 | -$67.56M 10-Q/A · filed 2017-03-31 | |
| 2016-06-30 | -$716.15M 10-Q · filed 2016-07-20 | |
| 2016-03-31 | -$712.77M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$48.92M 10-K · filed 2017-03-31 | -$706.24M 10-K · filed 2016-03-15 |
| 2015-09-30 | -$695.71M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | -$678.08M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | -$658.28M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | -$637.57M 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$617.22M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | -$597.25M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | -$574.97M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | -$551.41M 10-K · filed 2015-03-12 | |
| 2013-09-30 | -$527.25M 10-Q · filed 2013-11-04 | |
| 2013-06-30 | -$504.74M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$481.95M 10-Q · filed 2013-04-30 | |
| 2012-12-31 | -$461.22M 10-K · filed 2014-03-11 | |
| 2012-09-30 | -$443.10M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | -$428.10M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | -$413.48M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | -$398.43M 10-K · filed 2013-03-14 | |
| 2011-09-30 | -$387.69M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | -$374.95M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | -$351.05M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |